Document Type
Article
Publication Date
5-24-2016
Publication Title
BioMed Central Infectious Diseases
Department
Geisel School of Medicine
Abstract
Cervical cancer is the most common female cancer in Rwanda that, in 2011, became the first African country to implement a national vaccination programme against human papillomavirus (HPV). To provide a robust baseline for future evaluations of vaccine effectiveness, cervical cell specimens were obtained from 2508 women aged 18–69 years from the general population in Kigali, Rwanda, during 2013/14. 20 % of women were HIV-positive. Samples were used for liquid-based cytology and HPV testing (44 types) with GP5+/6+ PC.
DOI
10.1186/s12879-016-1539-6
Dartmouth Digital Commons Citation
Ngabo, Fidele; Franceschi, Silvia; Baussano, Iacopo; Umulisa, M. Chantal; Snijders, Peter; Uyterlinde, Anne; Lazzarato, Fulvio; Tenet, Vanessa; Gatera, Maurice; Binagwaho, Agnes; and Clifford, Gary, "Human Papillomavirus Infection in Rwanda at the Moment of Implementation of a National HPV Vaccination Programme" (2016). Dartmouth Scholarship. 626.
https://digitalcommons.dartmouth.edu/facoa/626
Included in
Community Health and Preventive Medicine Commons, Neoplasms Commons, Virus Diseases Commons
